MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Corticobasal degeneration (CBD)"

  • 2018 International Congress

    Usefulness of combined examination using Frontal Assessment Battery (FAB) and Single Photon Emission Computer Tomography in the differentiation of 4 repeats (4R) tauopathic atypical parkinsonism

    P. Alster, D. Koziorowski, L. Królicki, A. Friedman (Warsaw, Poland)

    Objective: The aim of the work is to analyze whether combined examination of the frontal lobe using single photon emission computer tomography (SPECT) and Frontal…
  • 2018 International Congress

    Referral and diagnostic time intervals from symptom onset to death in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Parkinson’s disease (PD)

    D. Swallow, C. Counsell (Aberdeen, United Kingdom)

    Objective: To compare referral and diagnostic time intervals from index symptom to death in PSP/CBD and age-sex matched PD. Background: Misdiagnosis and delayed diagnosis are…
  • 2017 International Congress

    Are a „mathematical brain“ and early childhood adverse events possible risk factors that contribute to Progressive Supranuclear Palsy?

    S. Lorenzl (Hausham, Germany)

    Objective: To evaluate possible risk factors for the development of Progressive Supranuclear Palsy (PSP). Background: Risk factors for the development of neurodegenerative brain disorders are…
  • 2017 International Congress

    Clinicopathological analysis of corticobasal syndrome: a retrospective study

    R. Lamb, J. Rohrer, R. Weil, H. Ling, A. Lees, H. Morris (London, United Kingdom)

    Objective: Predicting underlying pathology in CBS. Background: Corticobasal syndrome (CBS) is pathologically heterogeneous.  CBS is one of the clinical phenotypes of corticobasal degeneration (CBD) but may…
  • 2017 International Congress

    Gait impairment and cognitive changes in a case of thalamic dementia and motor neuron disease.

    S. O'Shea, O. Levy, J.P. Vonsattel, E. Cortes, K. Marder, H. Mitsumoto, R. Alcalay (New York, NY, USA)

    Objective: To describe a case of a 54-year-old woman diagnosed with atypical corticobasal syndrome (CBS). Neuropathological studies revealed that she had thalamic dementia with motor…
  • 2017 International Congress

    Creutzfeldt-Jakob Disease with Corticobasal Syndrome-Like Onset: Case report

    M. Gultekin, R. Baydemir, M.F. Gol, M. Mirza (Kayseri, Turkey)

    Objective: We present a 56-year-old man patient who diagnosed CJD with CBS-like onset. Background: Creutzfeldt-Jakob disease (CJD) is an untreatable rare human prion disease characterized…
  • 2017 International Congress

    Progressive supranuclear palsy presenting with corticobasal syndrome: a case report

    M. Sousa, R. Varela, C. Januário, A. Morgadinho (Coimbra, Portugal)

    Objective: Clinical description and interpretation of complementary diagnostic exams of a patient with probable PSP with corticobasal syndrome phenotype (PSP-CBS). Background: Underlying pathologies of CBS…
  • 2017 International Congress

    Corticobasal degeneration and frontotemporal dementia – an overlapping continuum

    R. Varela, C. Duque, J. Carvalho, A. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)

    Objective: This clinical case intends to highlight the continuum between frontotemporal dementia and corticobasal syndrome. Background: A substantive overlap between corticobasal degeneration and frontotemporal dementia…
  • 2017 International Congress

    In vivo evaluation of tau and amyloid pathology in Corticobasal Syndrome

    F. Niccolini, H. Wilson, S. Hirschbichler, G. Pagano, R. Erro, T. Yousaf, A. Whittington, J. Holton, D. Martino, E. Rabiner, R. Gunn, K. Bhatia, M. Politis (London, United Kingdom)

    Objective: To assess in vivo, with molecular imaging the brain distribution of tau aggregates ([18F]AV1451 PET) and β-amyloid depositions ([18F]AV45 PET) in patients with Corticobasal…
  • 2017 International Congress

    Dextrometorphan/quinidine in Atypical Parkinsonisms and Huntington Disease

    J. Etcheverry, M. Cesarini, G. Rojas, E. Gatto (Buenos Aires, Argentina)

    Objective: to determine whether Dextrometorphan/quinidine (DMQ) is effective in the treatment of PBA, AG or bulbar symptoms in corticobasal syndrome (CBS), multiple system atrophy (MSA),…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • #25136 (not found)
  • Unusual prolonged survival in multiple system atrophy: A case report
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley